针对透性肝细胞癌的系统疗法的治疗结果
Po-Yi Chen1,2, Chih-Kai Chang3, Bang-Bin Chen3
1Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
Journal of hepatocellular carcinoma
|June 30, 2025
概括
用免疫检查点抑制剂 (ICI) 治疗的透性肝细胞癌 (HCC) 的结果较差. 这项研究发现,接受基于ICI的治疗的透性HCC患者的治疗失败和整体存活时间较短.
科学领域:
- 肝细胞癌研究 肝细胞癌研究
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 对于不可切除的透性肝细胞癌 (HCC) 的结局尚不清楚.
- 透性HCC在临床试验中不足,限制了治疗结果数据.
研究的目的:
- 通过各种全身疗法探索透性HCC的治疗结果.
- 为了比较透性和多块性HCC亚型之间的结果.
主要方法:
- 对260名巴塞罗那诊所肝癌C期HCC患者接受一线全身治疗的回顾性分析.
- 透性和多块性HCC亚型之间的基线特征和治疗结果的比较.
主要成果:
- 透性HCC患者更有可能患有宏血管侵袭,但不太可能患有肝外传播.
- 多激酶抑制剂治疗显示了与治疗失败和两种HCC亚型的总生存时间相似的时间.
- 基于免疫检查点抑制剂 (ICI) 的治疗与透性HCC患者的治疗失败时间显著缩短和整体存活率较低有关.
结论:
- 透性HCC,当用ICI治疗治疗时,与明显较差的结果有关.
- 需要进一步的研究,以了解和改进透性HCC的治疗策略.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.5K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.4K
相关概念视频
Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
